U.S. Congress legislation · 119th Congress
SB4189: INSULIN Act of 2026
Status: In committee, August 7, 2026
A bill to reduce the price of insulin and provide for patient protections with respect to the cost of insulin.
What the bill says
To reduce the price of insulin and provide for patient protections with respect to the cost of insulin.
From the introduced text, August 7, 2026:
A BILL To reduce the price of insulin and provide for patient protections with respect to the cost of insulin. SECTION 1. Short title; table of contents (a) Short title This Act may be cited as the Improving Needed Safeguards for Users of Lifesaving Insulin Now Act of 2026 or the INSULIN Act of 2026 . (b) Table of contents The table of contents for this Act is as table of contents. Sec. 2. Sense of Congress. TITLE I--Commercial market patient protections Sec. 101. Requirements with respect to cost-sharing for certain insulin products. Sec. 102. Application to retiree and certain small group plans. Sec. 103. Administration. TITLE II--Pharmacy benefit manager transparency and rebate reform Sec. 201. Full rebate on insulin pass-through to plan. TITLE III--Biosimilar biological product and generic drug competition and affordability Sec. 301. Ensuring timely access to generics. Sec. 302. Expediting competitive biosimilar competition. Sec. 303. Insulin competition report. TITLE IV--Programs for providing affordable insulin to uninsured individuals Sec. 401. Pilot program for providing affordable insulin to uninsured individuals. Sec. 402. GAO study on uninsured individuals who use insulin. Sec. 403. Insulin resource center and hotline for uninsured individuals. SECTION 2. Sense of Congress It is the sense of Congress that Congress should enact subsequent legislation that provides for an offset for any costs to the Federal Government …
Sponsors
- Shaheen, Jeanne (D) · primary sponsor
- Collins, Susan (R)
- Warnock, Raphael (D)
- Kennedy, John (R)
- Rosen, Jacky (D)
- Tuberville, Tommy (R)
- King, Angus (I)
- Murkowski, Lisa (R)
- Kelly, Mark (D)
- Grassley, Chuck (R, SD-IA)
- Baldwin, Tammy (D)
- Katie Boyd Britt (R, SD-AL)
Latest actions
- : Placed on Senate Legislative Calendar under General Orders. Calendar No. 552.
- : Committee on Health, Education, Labor, and Pensions. Reported by Senator Cassidy with an amendment in the nature of a substitute. Without written report.
- : Committee on Health, Education, Labor, and Pensions. Ordered to be reported with an amendment in the nature of a substitute favorably.
- : Introduced in Senate
- : Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
Subjects: Health programs administration and funding, Health care coverage and access, Civil actions and liability, Competition and antitrust, Drug therapy, Digestive and metabolic diseases, Drug safety, medical device, and laboratory regulation, Government information and archives
Common questions
- What is SB4189?
- SB4189 is a bill in Congress (119th Congress): INSULIN Act of 2026.
- What does SB4189 do?
- In its own words: To reduce the price of insulin and provide for patient protections with respect to the cost of insulin.
- What is the status of SB4189?
- In committee as of August 7, 2026. Latest action: Placed on Senate Legislative Calendar under General Orders. Calendar No. 552. (August 7, 2026).
- Who sponsored SB4189?
- Shaheen, Jeanne (D), with 11 co-sponsors.
- Where is the official record for SB4189?
- On the Congress website: https://www.congress.gov/bill/119th-congress/senate-bill/4189
Source: official Congress record. Tracked by Delilah, AI for legislation across all 50 states and Congress.